Joseph Lewis is 10% Owner at Mirati Therapeutics, Inc. (MRTX). They have made 12 open-market trades across 6 companies since 2009, most recently 2025-09-12.
CIK 0001015747
7 open-market purchases totalling $52.0M since 2017, against 5 sales. Across 7 scored buys the stock is up 27.7% at ninety days, and 22.0 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 71% | 71% | 100% |
| Avg Move | +13.1% | +17.7% | +27.7% |
| Alpha | +12.8% | +16.3% | +22.0% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TNGX | BUY | 2022-10-04 | 2022-10-06 | $3.93 | $1.1M | +60.7% | +83.9% | +82.9% |
| MRTX | SELL | 2021-03-05 | 2021-03-09 | $181.15 | $72.5M | -9.1% | -15.0% | -13.8% |
| MRTX | SELL | 2020-10-28 | 2020-10-30 | $208.38 | $154.5M | +7.1% | +11.0% | -4.8% |
| ODT | BUY | 2020-09-28 | 2020-09-30 | $13.63 | $2.9M | +14.1% | -0.1% | +19.8% |
| ODT | BUY | 2020-09-04 | 2020-09-09 | $14.99 | $3.4M | -6.5% | +2.7% | +3.9% |
| INSG | BUY | 2018-12-19 | 2018-12-20 | $3.00 | $29.3M | +13.2% | +37.7% | +36.4% |
| ODT | BUY | 2018-10-24 | 2018-10-26 | $14.72 | $790K | +15.8% | +0.1% | +10.6% |
| ODT | BUY | 2018-03-22 | 2018-03-26 | $22.73 | $4.5M | -7.0% | -7.3% | +9.3% |
| ODT | BUY | 2017-12-06 | 2017-12-08 | $24.00 | $10.0M | +1.5% | +6.5% | +30.6% |
| SPHS | SELL | 2014-12-15 | 2014-12-17 | $0.61 | $538K | N/A | N/A | N/A |
| SOMX | SELL | 2009-08-26 | 2009-08-28 | $2.64 | $251K | N/A | N/A | N/A |
| SOMX | SELL | 2009-07-27 | 2009-07-29 | $3.10 | $1.6M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.